Newcastle Clinical Trials Unit



The main source of income for NCTU activity is project grants.

The National Institute of Health Research (NIHR) is a major funder of these projects. This funding come through the funding streams managed by NIHR Central Commissioning Facility:

NIHR funding is also provided by streams managed by the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC):

Other sources of project funding include:

Industry funding includes Novartis, Roche and Bristol-Myers-Squibb.

As a UKCRC registered CTU based in England, and with a strong track record in winning funding from the NIHR funding streams managed through NETSCC, NCTU is in receipt of NIHR Clinical Trials Unit Support Funding, which provides pump-priming resources.